Literature DB >> 18828428

Causative agents of urinary tract infections in children and their antibiotic sensitivity pattern: a hospital based study.

G K Rai1, H C Upreti, S K Rai, K P Shah, R M Shrestha.   

Abstract

A retrospective study was conducted to find out the causative agents of urinary tract infection (UTI) in children and their antibiotic sensitivity pattern among Nepalese children. This was done at Kanti Children's Hospital in Kathmandu (Nepal) by analyzing the records of urine samples collected for culture and sensitivity tests over a period of six months (April to November, 2007). Of the total 1878 mid-stream urine samples collected from suspected cases of UTI, 538 (28.6%) were positive for pathogenic organisms. There was no significant difference in growth positive rate in two genders (M: 51.7% and F: 48.3%). Of the various pathogenic organisms isolated, Escherichia coli constituted for 93.3% followed by Proteus sp, Klebsiella sp, Citrobacter sp, Staphylococcus aureus and others. E. coli was found to be most sensitive to amikacin, chloramphenicol, nitrofurantoin and ofloxacin and least sensitive to most commonly used drugs like cephalexin, nalidixic acid, cotrimoxazole and norfloxacin.

Entities:  

Mesh:

Year:  2008        PMID: 18828428

Source DB:  PubMed          Journal:  Nepal Med Coll J


  11 in total

1.  Application of WHONET in the Antimicrobial Resistance Surveillance of Uropathogens: A First User Experience from Nepal.

Authors:  A N Ghosh; D R Bhatta; M T Ansari; H K Tiwari; J P Mathuria; A Gaur; H S Supram; S Gokhale
Journal:  J Clin Diagn Res       Date:  2013-05-01

2.  High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal.

Authors:  Pankaj Baral; Sanjiv Neupane; Bishnu Prasad Marasini; Kashi Ram Ghimire; Binod Lekhak; Basudha Shrestha
Journal:  BMC Res Notes       Date:  2012-01-19

Review 3.  Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis.

Authors:  Ashley Bryce; Alastair D Hay; Isabel F Lane; Hannah V Thornton; Mandy Wootton; Céire Costelloe
Journal:  BMJ       Date:  2016-03-15

4.  ESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study.

Authors:  Pooja Shakya; Dhiraj Shrestha; Elina Maharjan; Vijay K Sharma; Rabin Paudyal
Journal:  Open Microbiol J       Date:  2017-04-28

5.  High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal.

Authors:  Narayan Prasad Parajuli; Pooja Maharjan; Hridaya Parajuli; Govardhan Joshi; Deliya Paudel; Sujan Sayami; Puspa Raj Khanal
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-11       Impact factor: 4.887

6.  Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal.

Authors:  Lok Bahadur Shrestha; Ratna Baral; Prakash Poudel; Basudha Khanal
Journal:  BMC Pediatr       Date:  2019-01-29       Impact factor: 2.125

Review 7.  Antimicrobial Resistance in Nepal.

Authors:  Krishna Prasad Acharya; R Trevor Wilson
Journal:  Front Med (Lausanne)       Date:  2019-05-24

8.  Drug Prescribing Patterns in Pediatric Urinary Tract Infections: A Retrospective Drug Utilization Analysis in an Urban Tertiary Care Hospital.

Authors:  Srinidhi Govindarajan; Preethi J Shenoy
Journal:  J Pharm Bioallied Sci       Date:  2020-10-08

9.  Bacterial Uropathogens Causing Urinary Tract Infection and Their Resistance Patterns Among Children in Turkey.

Authors:  Yunus Yilmaz; Zuhal Tekkanat Tazegun; Emsal Aydin; Mahmut Dulger
Journal:  Iran Red Crescent Med J       Date:  2016-05-21       Impact factor: 0.611

10.  Enhanced quantitative urine culture technique, a slight modification, in detecting under-diagnosed pediatric urinary tract infection.

Authors:  Januka Thapaliya; Priyatam Khadka; Shovana Thapa; Chenu Gongal
Journal:  BMC Res Notes       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.